Abstract: Intracellular communication from the mitochondria to the nucleus is achieved via the retrograde response. In budding yeast, the retrograde response, also known as the RTG pathway, is regulated positively by Rtg1, Rtg2, Rtg3 and Grr1 and negatively by Mks1, Lst8 and two 14-3-3 proteins, Bmh1/2. Activation of retrograde signaling leads to activation of Rtg1/3, two basic helix-loop-helix leucine zipper transcription factors. Rtg1/3 activation requires Rtg2, a cytoplasmic protein with an N-terminal adenosine triphosphate (ATP) binding domain belonging to the actin/Hsp70/sugar kinase superfamily. The critical regulatory step of the retrograde response is the interaction between Rtg2 and Mks1. Rtg2 binds to and inactivates Mks1, allowing for activation of Rtg1/3 and the RTG pathway. When the pathway is inactive, Mks1 has dissociated from Rtg2 and bound to Bmh1/2, preventing activation of Rtg1/3. What signals association or disassociation of Mks1 and Rtg2 is unknown. Here, we show that ATP at physiological concentrations dissociates Mks1 from Rtg2 in a highly cooperative fashion. We report that ATP-mediated dissociation of Mks1 from Rtg2 is conserved in two other fungal species, K. lactis and K. waltii. Activation of Rtg1/3 upregulates expression of genes encoding enzymes
Introduction
M energy currency in eukaryotic cells. Apart from their metabolic function, mitochondria participate in a diverse array of physiological processes, such as apoptosis, cancer, degenerative diseases and aging [1 4 ]. Due to the versatility of mitochondrial functions, it's critically important for cells to monitor the functional state of mitochondria and adjust nuclear gene expression accordingly to achieve functional homeostasis of mitochondrial activity. This is achieved via the coordination of mitochondria-to-nucleus signaling pathways, known as the retrograde response [5, 6] . The retrograde response adapts cells to changes in the functional state of mitochondria, such as respiratory defects, by mediating an assortment of cellular processes that include metabolic reconfiguration, nutrient sensing, aging and stress response pathways [7 12 ]. Retrograde response pathways have been reported in many eukaryotic organisms, including fungi, plants and animals [5,6,13 16] . In the budding yeast, Saccharomyces cerevisiae, the retrograde response, also known as the RTG pathway, mediates expression of many genes encoding proteins that function in small molecule transport, anaplerotic pathways, pleotropic drug resistance, aging and peroxisomal biogenesis [7,17 22] .
The prototypal target gene of the RTG pathway is CIT2, encoding the peroxisomal isoform of citrate synthase [23, 24] . In cells with reduced mitochondrial respiratory functions, CIT2 expression is greatly induced, which requires three Rtg proteins, Rtg1, Rtg2 and Rtg3 [23, 25] . Rtg1 and Rtg3 are two basic helix-loop-helix leucine zipper transcription factors that bind as a heterodimer to the promoter region of CIT2 and activate CIT2 expression [25] . Activation and nuclear translocation of Rtg1 and Rtg3 correlate with dephosphorylation of Rtg3 [26, 27] . These processes require a novel cytoplasmic protein, Rtg2, which contains an N-terminal ATP binding domain of the Hsp70/acting/sugar kinase ATP binding domain superfamily [28 30] . The integrity of the ATP binding domain of Rtg2 is important for its interaction with Mks1 [28] . However, the underlying mechanism is still unknown. Activity of Rtg1 and Rtg3 can also be mediated by the target of the rapamycin (Tor) signaling pathway and the mitogen-activated protein kinase, Hog1, in the osmoregulatory signal transduction cascade, linking the retrograde response to other nutrient sensing and stress response pathways [28,31 34] .
One main function of the RTG pathway is the biosynthesis of glutamate in cells with compromised respiratory functions [6] . Transcriptional regulation of the Krebs cycle genes, CIT1, ACO1, IDH1 and IDH2, switches from the Hap2-5 complex to the Rtg1/3 complex in cells with respiratory deficiencies [18] . The products of these genes, as well as CIT2 promote the synthesis of -ketoglutarate, a precursor of glutamate. Mutations in RTG genes lead to glutamate auxotrophy in respiratory-deficient cells, underlying the role of the RTG pathway in glutamate homeostasis [18] . As a feedback control mechanism, glutamate is a potent repressor of the RTG pathway.
Activation of Rtg1 and Rtg3 by Rtg2 is indirect, and additional regulatory factors function between Rtg2 and Rtg1/3 [6] . These include a novel cytoplasmic protein, Mks1, Lst8 (a component of the Tor kinase complexes), Grr1 (a component of the SCF Grr1 E3 ubiquitin ligase) and two 14-3-3 proteins, Bmh1 and Bmh2 [28,32,33,35 41] . With the exception of Grr1, all of these factors are negative regulators of the RTG pathway. Among these proteins, Mks1 is a key regulatory component [6] . When active, Mks1 is dissociated from Rtg2, hyperphosphorylated and able to bind to Bmh1/2. Bmh1/2 binding prevents the SCF Grr1 E3 ubiquitin ligase-mediated ubiquitination and degradation of Mks1 [38] . It has been reported that Mks1 interacts with Tor1 and Tor2 kinases [42] . Since both Mks1 and Tor kinases are negative regulators of the RTG pathway, it is likely that the Mks1-Tor complex may directly phosphorylate and inactivate Rtg3. The role of Lst8 in the retrograde response pathway may also be linked to its role in the TOR kinase complexes.
The positive regulatory role of Rtg2 in the retrograde response is to bind to and inactivate Mks1. We have previously proposed that the interaction between Rtg2 and Mks1 constitutes a binary switch that turns the RTG pathway on or off [6, 38] . A major unanswered question remains: What is the signaling molecule that mediates the interaction between Rtg2 and Mks1? Here, we present evidence to suggest that ATP is that signaling molecule. At physiological concentrations, ATP has an all-or-none effect on the interaction between Rtg2 and Mks1. We further show that ATP-dependent regulation of this interaction is evolutionarily conserved.
Experimental Section

Strains, Plasmids and Growth Media and Growth Conditions
Yeast strains and plasmids used in this study are listed in Tables 1 and 2 , respectively. Yeast cells were grown in SD (0.67% yeast nitrogen base plus 2% dextrose), YNBcasD (SD medium plus 1% casamino acids) or YPD (1% yeast extract, 2% peptone, 2% dextrose) medium at 30 °C. When necessary, amino acids, adenine and/or uracil, were added to the growth medium at standard concentrations to cover auxotrophic requirements or at concentrations as indicated in the text and/or figure legends [43] . When needed, glutamate was added to the growth medium at the final concentration of 0.2% to inhibit the RTG pathway. This study Figure 5 
Cellular Extracts Preparation, Immunoprecipitation and Immunoblotting
Total cellular protein extracts were prepared by using the NaOH--mercaptoethanol method as described [44] . For interaction assays between Rtg2 and Mks1 in the presence of ATP or other nucleotides, cellular lysates were prepared in IP buffer (20 mM Hepes-KOH pH 7.6, 150 mM KCl, 10 mM MgCl, 0.5% Triton X-100 and protease inhibitors). Cell extracts (~1.6 mg proteins) were incubated at 4 °C with ATP or other nucleotides as indicated for 1.5 h, after which 2 g anti-myc antibody (9E10, Roche) was added and incubated for 1.5 h. Forty microliters 50% slurry of protein G-Sepharose (Roche) was then added to each sample, and the samples were further incubated at 4 °C for 2 h. Immunoprecipitates were washed five times each with 1 ml IP buffer. Proteins bound to the Sepharose beads were released by boiling in 1X SDS-PAGE loading buffer. The released immune complexes were analyzed by SDS-PAGE and immunoblotting. myc and HA-tagged proteins were probed with anti-myc antibody 9E10 and anti-HA antibody 12CA5, respectively. To determine the effect of nucleotides on the dissociation of Rtg2 and Mks1, immunoprecipitates of Rtg2-myc and Mks1-HA were prepared using the procedure mentioned above, with the exception that ATP was not used. The immunopurified Rtg2-Mks1 complex was then incubated in the presence of various nucleotides at indicated concentrations for 5 minutes at 23 °C, after which the supernatant and pellet fractions were obtained by 2 min. of centrifugation. Rtg2-myc and Mks1-HA in the supernatant and pellet fractions were separated by SDS-PAGE and detected by immunoblotting.
Yeast Transformation and -Galactosidase Activity Assays
Plasmids were transformed into yeast strains using the high-efficiency lithium acetate-PEG method [43] . -galactosidase assays were carried out as described [43] . For each plasmid and strain combination, assays were conducted in triplicate, and independent experiments were carried out two or three times.
Results and Discussion
ATP, but not ADP or AMP-PNP, at High Concentrations Disrupts the Interaction between Rtg2 and Mks1 in Total Cellular Lysates
Retrograde signaling is regulated by the dynamic interaction between Rtg2 and Mks1. When the RTG pathway is inactive, Mks1 is dissociated from Rtg2 and inhibits Rtg1/3. When the RTG pathway is active, Mks1 is sequestered by Rtg2. To understand the mechanism by which this interaction is regulated, we tested candidate molecules that may mediate the interaction between Rtg2 and Mks1. Since Rtg2 has an N-terminal ATP binding domain and ATP is produced by mitochondria through oxidative phosphorylation, one possible candidate signaling molecule is ATP. We hypothesized that ATP production from robust mitochondrial respiratory metabolism releases Mks1 from Rtg2 to inhibit the RTG pathway, which may explain why the RTG pathway is not active in cells with robust respiration. Accordingly, we tested whether ATP affects the interaction between Rtg2 and Mks1. We prepared cellular extracts from cells co-expressing functional myc-tagged Rtg2 and HA-tagged Mks1 and incubated with different concentrations of ATP. We then immunoprecipitated Rtg2-myc with anti-myc anti-body immobilized on protein G Sepharose beads and determined the amount of Mks1-HA in the Rtg2-myc immunoprecipitates. Figure 1 shows that without the addition of exogenous ATP, Mks1-HA was efficiently pulled down with Rtg2-myc. Similarly, treatment with 1 and 2 mM ATP had little or no effect on the interaction between Rtg2 and Mks1. Interestingly, treatment with 5 mM ATP greatly reduced the amount of Mks1-HA recovered in the Rtg2-myc immunoprecipitates. In contrast, treatment with 5 mM ADP had little effect on the interaction between Rtg2 and Mks1. We also treated total cellular extracts with 5 mM --imido) triphosphate (AMP-PNP), which is a non-hydrolysable analogue of ATP, and found that it also had no effect on the interaction between Rtg2-myc and Mks1-HA, suggesting that ATP hydrolysis may be required for the release of Mks1 from Rtg2.
ATP within a Small Range of Physiological Concentrations Releases Mks1 from an Immunopurified Rtg2-Mks1 Complex
Rtg2 has a predicted N-terminal ATP binding domain, the integrity of which is important for the function of Rtg2 [28, 29] . Data in Figure 1 suggest that ATP may directly bind to Rtg2, resulting in Mks1 release. Before testing this possibility, we considered that total cellular lysates contain several thousand proteins, potentially complicating interaction analysis between Mks1 and Rtg2. Therefore, using aliquots of an immunopurified complex, we tested the effect of ATP at various concentrations on the interaction between Rtg2 and Mks1. In preliminary experiments, we found that 5 mM ATP can lead to maximum release of Mks1 from Rtg2, and a further increase to up to 10 mM did not result in the release of more Mks1 from Rtg2 (data not shown). Therefore, we treated the Rtg2-Mks1 complex with 0~6 mM ATP at 1 mM intervals. Figure 2A shows that while treatment with 1~3 mM ATP had little or no effect on the interaction between Rtg2 and Mks1, 5 and 6 mM ATP treatment efficiently released Mks1-HA from Rtg2-Mks1, and 4 mM ATP had an intermediate effect. Quantitative analysis of data in Figure 2A shows that ~50% Mks1 is released from Rtg2 in the presence of 5~6 mM ATP ( Figure 2B ). The appearance of Mks1 in the supernatant fraction was not due to the release of Rtg2-myc from anti-myc antibody immobilized on the protein G Sepharose beads, since Rtg2-myc was not detected in the supernatant fraction of samples treated with different concentrations of ATP. Next, we examined the effect of three other purine nucleotides, ADP, GTP and GDP, and two ATP analogs, AMP-PNP and 5'-O-(3-thio) triphosphate (ATP S), on the interaction between Rtg2 and Mks1. We found that at 5 mM concentration, ADP, GTP or GDP had no effect. At 10 mM concentration, the non-hydrolysable ATP analog, AMP-PNP, also had no effect. Interestingly, at 10 mM concentration, ATP S, a slowly hydrolysable ATP analog [45, 46] , could weakly dissociate Mks1 from Rtg2. Together, this data indicate that Mks1 release from Rtg2 by ATP is specific and that ATP hydrolysis is required for this process.
Figure 1. Adenosine triphosphate (ATP) disrupts the interaction between Rtg2 and Mks1
in total cellular lysates. Cellular lysates prepared from yeast cells expressing Rtg2-myc and/or Mks1-HA as indicated were analyzed for the effect of ATP, ADP and --imido) triphosphate (AMP-PNP) on the interaction between Rtg2 and Mks1 by immunoprecipitation, as described in the Experimental Section. Cellular lysates were treated with the nucleotides at indicated concentrations, and Rtg2-myc was immunoprecipitated using anti-myc anti-body and protein G Sepharose beads. Rtg2-myc and Mks1-HA in IP pellet fractions were detected by immunoblotting.
We attempted to purify recombinant Rtg2 and Mks1 to determine whether these two proteins alone are sufficient to recapitulate the ATP effect observed with immunopurified complex. However, numerous attempts made to purify recombinant Rtg2 from bacterial, yeast and insect cells failed, due to its insolubility. Therefore, the possibility that other proteins in the immunopurified Rtg2-Mks1 complex contribute to their interaction or dissociation upon ATP treatment cannot be ruled out.
Intracellular ATP concentration is estimated to be in the range of 1 5 mM [47, 48] . The data in Figure 2 present two striking observations: ATP has an all-or-none effect on the interaction between Rtg2 in Mks1; the concentration of ATP that dramatically changes the interaction between Rtg2 and Mks1 is within the physiological range. Since activation of the RTG pathway leads to increased expression of genes encoding citrate synthase, aconitase and isocitrate dehydrogenase, increased activities of these enzymes are expected to lead to increased metabolic flux into the Krebs cycle and ATP production in mitochondria. Our data in Figure 2 shows that ATP dissociates Mks1 from Rtg2, which results in inhibition of the RTG pathway. Taken together, we propose that ATP is the mitochondria-derived signaling molecule that turns off the pathway to achieve ATP homeostasis. ATP is the universal energy currency in biological systems; therefore, if our hypothesis is correct, we expect to find that the interaction between Mks1 and Rtg2 homologs in other fungal species is similarly regulated by ATP. 
RTG2 Homologs from K. lactis and K. waltii Complement an rtg2 Mutation in S. cerevisiae
Two fungal species, K. lactis and K. waltii, contain both Rtg2 and Mks1 homologs [49] . If the retrograde response pathway in budding yeast mediates ATP homeostasis, we expect the effect of ATP on the release of Mks1 from Rtg2 to be conserved in other fungal species. To test this possibility, we first cloned the RTG2 homologs from K. lactis and K. waltii and determined whether they complement an rtg2 mutation in S. cerevisiae.
The Rtg2 homolog in K. lactis and in K. waltii is a 587 and 583-residue protein, respectively. Both proteins show ~69% sequence identity to S. cerevisiae Rtg2 (data not shown). As reported previously, the RTG pathway is required for the biosynthesis of -ketoglutarate, the precursor to glutamate, and an rtg2 mutant strain is unable to grow on minimal SD medium without glutamate ( Figure 3A ) [18, 23] . Expression of the Rtg2 homolog from both K. lactis and K. waltii under the control of the S. cerevisiae RTG2 promoter enabled rtg2 mutant cells to grow on SD medium without glutamate ( Figure 3A) . Expression of CIT2, encoding the peroxisomal isoform of citrate synthase, requires Rtg2 [23] . Figure 3B shows that expression of Rtg2 homologs from K. lactis and K. waltii restored expression of CIT2-lacZ in rtg2 mutant cells to near wild-type levels. Together, these data suggest that the function of Rtg2 is conserved. (A) RTG2 homologs complement glutamate auxotrophy phenotype of rtg2 in S. cerevisiae. Wild-type (WT, PSY142) and rtg2 (PSY142-rtg2) mutant cells carrying empty vector or centromeric plasmids encoding RTG2 genes from K. lactis (K.la) and K. waltii (K.wa) were grown on SD medium with or without glutamate at 30 °C for 2 3 days. (B) Expression of RTG2 homologs restores expression of a CIT2-lacZ reporter to rtg2 mutant cells in S cerevisiae. Yeast strains described for panel (A) were grown in YNBcasD medium to mid-log phase, and -galactosidase assays were conducted as described in the Experimental Section. The Mks1 homolog in K. lactis and K. waltii is a 638 and 588-residue protein, respectively. Unlike Rtg2 proteins, Mks1 proteins are much less conserved: S. cerevisiae Mks1 shares ~29% sequence identity with its homologs in K. lactis and K. waltii (data not shown). We tested whether Mks1 homologs could complement an mks1 mutation in S. cerevisiae. Mks1 is a negative regulator of the RTG pathway, and an mks1 mutation bypasses the requirement of Rtg2 for cells to grow on medium without glutamate [33, 35] . Therefore, we generated plasmids encoding MKS1 homologs under the control of the MKS1 promoter from S. cerevisiae and transformed them into rtg2 mks1 double mutant cells. Figure 4A shows that expression of the Mks1 homologs in rtg2 mks1 double mutant cells resulted in glutamate auxotrophy, indicating that Mks1 homologs from K. lactis and K. waltii are functional in S. cerevisiae.
Mks1 is a phosphoprotein, whose phosphorylation correlates with its activity in cells: when it is bound to Rtg2 and inactive, Mks1 is hypophosphorylated; when the RTG pathway is inactive, Mks1 becomes hyperphosphorylated [33, 35] . We then determined whether the regulation of Mks1 is also conserved. Figure 4B shows that in the presence of glutamate, which inhibits the retrograde pathway, Mks1 proteins from S. cerevisiae, K. lactis and K. waltii, all became hyperphosphorylated. Mks1 phosphorylation in S. cerevisiae is also dependent on the availability of Rtg2: in the absence of Rtg2, Mks1 becomes hyperphosphorylated ( Figure 4C ) [33, 35] . We found that the Mks1 homologs from K. lactis and K. waltii were also hyperphosphorylated in rtg2 mutant cells ( Figure 4C ). Together, these data suggest that the function and regulation of Mks1 proteins are conserved.
ATP at Physiological Concentrations Releases Mks1 Homologs from its Cognate Rtg2
Homologs from K. lactis and K. waltii After confirming that Rtg2 and Mks1 homologs from K. lactis and K. waltii are functional, we then looked at whether interactions between Rtg2 and Mks1 homologs are regulated by physiological concentrations of ATP. Figure 5A shows that when expressed in S. cerevisiae rtg2 mks1 double mutant cells, pairs of Mks1 and Rtg2 from S. cerevisiae, K. lactis and K waltii form a complex using co-immunoprecipitation. We then immunopurified K. lactis and K. waltii Rtg2-Mks1 complexes and treated them with ATP at different concentrations. Figure 5 B and C show that 1 3 mM ATP had little or no effect on Mks1 release from Rtg2. Treatment with 4 mM ATP resulted in maximal release of Mks1 from Rtg2. Similar effects of physiological levels of ATP on the interaction of Rtg2 and Mks1 in three different fungal species strongly suggest that the RTG pathway mediates ATP homeostasis.
Cellular energy homeostasis has been proposed to be mediated by AMP-activated protein kinase (AMPK) in eukaryotes [50, 51] . AMPK is activated by a rise in the AMP:ATP ratio. When cellular energy levels drop, AMP levels rise, which leads to the activation of AMPK. Once activated, AMPK turns on catabolic pathways that generate ATP and turns off processes that utilize ATP. The S. cerevisiae AMPK, Snf1, is required for cell growth on less preferred fermentable and non-fermentable carbon sources, conditions that often require robust mitochondrial respiratory function [52, 53] . Since the RTG pathway is more active in respiratory deficient cells, we propose that the RTG pathway and AMPK may regulate energy homeostasis under different conditions. It is also possible that these two may work together to achieve finer control of cellular energy levels. 
Conclusions
The retrograde response senses changes in the functional state of mitochondria and adjusts nuclear gene expression accordingly. The signaling molecule linking the functional state of the mitochondria to the RTG pathway has been elusive. Here, we provide evidence that ATP may be this long sought-after signaling molecule. A key regulatory step of this pathway is the interaction between Rtg2 and Mks1. We find that ATP has an all-or-none effect on releasing Mks1 from Rtg2 in three different fungal species. Furthermore, the concentration of ATP that elicits the all-or-none effect is within the physiological range of ATP. We report that Rtg2 and Mks1 homologs from two other fungal species, K. lactis and K. waltii, are able to complement rtg2 and mks1 mutations in S. cerevisiae, respectively. Rtg2 and Mks1 homologs from K. lactis and K. waltii can form a complex, and their interaction is similarly regulated by ATP. Here, we propose that the retrograde response mediates ATP homeostasis by participating in a conserved negative feedback loop that responds to ATP levels to shut off ATP production when ATP is in excess: the RTG pathway regulates the expression of genes encoding the first three Krebs cycle enzymes, and activation of this pathway is expected to increase the metabolic flux into the Krebs cycle and ATP synthesis in mitochondria ( Figure 6A ). When the level of cellular ATP reaches a certain threshold (3 4.5 mM), ATP releases Mks1 from Rtg2 to turn off the RTG pathway ( Figure 6B ). Together, these two processes help achieve cellular ATP homeostasis. 
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